MedTrace Logo

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

NCT05888649 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-06-05

No results posted yet for this study

Summary

This community-based mixed methods study intends to identify, explore, and assess the determinants of community preparedness for outbreak situations, including acceptance for Ebola vaccines.

Conditions

  • Ebola Virus Disease

Interventions

BEHAVIORAL

Community Clusters

Assessment of the determinants for community preparedness to EVD outbreaks and acceptance of EVD vaccines.

Sponsors & Collaborators

  • West African Consortium for Clinical Research on Epidemic Pathogens (WAC-CREP)

    collaborator UNKNOWN

  • UL-PIRE Africa Center

    lead OTHER

Principal Investigators

  • Stephen B Kennedy, MD, MPH · UL-PIRE Africa Center, University of Liberia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Liberia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888649 on ClinicalTrials.gov